M. Rieger

发表

Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the β-Sheet Structure of MIF*

H. Ehrlich, R. Hoet, T. Calandra, 2012, The Journal of Biological Chemistry.

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

G. Remuzzi, J. Grünfeld, G. Kaplanski, 2005, Blood.

Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity.

É. Oksenhendler, C. Brun-Buisson, S. Ferrari, 2007, Blood.

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.

F. Dorner, P. Knöbl, M. Dockal, 2003, Blood.

Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA)

G. Remuzzi, S. Ferrari, J. K. Kremer Hovinga, 2006, Thrombosis and Haemostasis.

11 cases ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of Efficiency of curative and prophylactic treatment with rituximab in

G. Remuzzi, G. Kaplanski, O. Hermine, 2013 .

Efﬁciency of curative and prophylactic treatment with rituximab in ADAMTS13-deﬁcient thrombotic thrombocytopenic purpura: a study of 11 cases

G. Remuzzi, J. Grünfeld, G. Kaplanski, 2005 .

ADAMTS13 activity a first episode of thrombotic microangiopathy with undetectable and inhibitory effect) in a cohort of 35 adult French patients undergoing Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer,

C. Brun-Buisson, S. Ferrari, J. Mira, 2013 .

hemoglobin ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by Fatal congenital thrombotic thrombocytopenic purpura with apparent

B. Lämmle, M. Hermann, F. Scheiflinger, 2013 .

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin.

B. Lämmle, M. Hermann, J. K. Kremer Hovinga, 2005, Blood.

ADAMTS13 autoantibody detection by quantitative immunoblotting.

H. Schwarz, K. Váradi, P. Turecek, 2003, Blood.

Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA.

S. Ferrari, M. Dockal, F. Scheiflinger, 2004 .

Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions

H. Tilg, A. Moschen, H. Ehrlich, 2015, The Journal of Immunology.

IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

S. Ferrari, J. K. Kremer Hovinga, F. Scheiflinger, 2009, Journal of thrombosis and haemostasis : JTH.

Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation.

S. Ferrari, J. Fuhrmann, F. Scheiflinger, 2006, Blood.

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.

B. Lämmle, G. Remuzzi, P. Mannucci, 2005, Blood.

Essai diagnostique pour anticorps anti-protease de clivage de facteur de willebrand (adamts13)

F. Scheiflinger, B. Plaimauer, M. Rieger, 2004 .

mutation combination of common amino acid polymorphisms and a missense Modulation of ADAMTS13 secretion and specific activity by a

J. Fuhrmann, F. Scheiflinger, B. Plaimauer, 2013 .

IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

S. Ferrari, F. Scheiflinger, A. Veyradier, 2009, Journal of thrombosis and haemostasis : JTH.

Immunoprofile studies in patients with pulmonary tuberculosis. IV. Tuberculin skin reaction and test of inhibition of blood leukcoyte migration.

M. Rieger, L. Trnka, J. Škvor, 1979, Scandinavian journal of respiratory diseases.